GlassScriptPhysician profile
Joseph S Morse
NPI 1013600618
$1,491.51
in general payments reported to CMS, 2019-2025
17 companies · $667 in 2025
The $667 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $215 · 2024: $610 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $332.03 | 2024-2025 | Impella |
| Recor Medical INC | $196.85 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Boston Scientific Corporation | $193.33 | 2024-2025 | Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $148.86 | 2023-2024 | Farxiga, Wainua |
| Lexicon Pharmaceuticals, INC. | $121.83 | 2024 | Inpefa |
| Cardiva Medical, INC. | $105.59 | 2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.90 | 2023 | Lifevest |
| Medtronic, INC. | $62.48 | 2024 | Linq II |
| Abbott Laboratories | $38.91 | 2023 | Cardiomems, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $36.19 | 2023-2024 | |
| Terumo Medical Corporation | $35.94 | 2024-2025 | Angio-Seal, Navicross, Azur Cx Detachable |
| Teleflex LLC | $27.87 | 2025 | Vascband |
| Cordis US Corp. | $24.45 | 2023 | Zephyr |
| Edwards Lifesciences Corporation | $18.75 | 2024 | |
| Chiesi USA, INC. | $17.69 | 2023 | Kengreal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.59 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $15.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.